NBIX - Neurocrine Biosciences Inc. (NBIX) CEO Kevin Gorman on Q4 2021 Results - Earnings Call Transcript
Neurocrine Biosciences, Inc. (NBIX) Q4 2021 Results Conference Call February 11, 2022 08:00 AM ET Company Participants Todd Tushla - Vice President, Investor Relations Kevin Gorman - Chief Executive Officer and Director Matt Abernethy - Chief Financial Officer Dr. Eiry Roberts - Chief Medical Officer Eric Benevich - Chief Commercial Officer Kyle Gano - Chief Business Development and Strategy Officer Conference Call Participants Phil Nadeau - Cowen Paul Matteis - Stifel Tazeen Ahmad - Bank of America Brian Abrahams - RBC Capital Markets Anupam Rama - JPMorgan Carter Gould - Barclays Neena Bitritto-Garg - Citi Myles Minter - William Blair Joshua Schimmer - Evercore David Amsellem - Piper Sandler Jay Olson - Oppenheimer Vamil Divan - Mizuho Securities Marc Goodman - SBC Leerink Charles Duncan - Cantor Fitzgerald Chris Shibutani - Goldman Sachs Evan Seigerman - BMO Capital Markets Jeff Hung - Morgan Stanley Presentation Operator Good day, everyone, and
For further details see:
Neurocrine Biosciences, Inc. (NBIX) CEO Kevin Gorman on Q4 2021 Results - Earnings Call Transcript